Characterizing the 'Feel-Good Experience' in Multiple Sclerosis Patients Treated with Natalizumab or Other Therapies.
NEURODEGENERATIVE DISEASE MANAGEMENT（2023）
Key words
disease-modifying therapy,feel-good experience,multiple sclerosis,natalizumab,patient management,patient-reported outcomes,quality-of-life,real-world evidence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined